BOOSTRIX Polio susp inj (n ser pré) 10 x 0.5 ml

7680006810044 CH-681 J07CA02 08.08.
BOOSTRIX Polio susp inj (n ser pré) 10 x 0.5 ml
BOOSTRIX Polio susp inj (n ser pré) 10 x 0.5 ml
BOOSTRIX Polio susp inj (n ser pré) 10 x 0.5 ml
1 / 3
google

Details

Product number
0068101
CPT
-
Packaging group
10
Unit
Fertigspritze(n)
Composition
toxoidum diphtheriae ≥ 2 U.I., toxoidum tetani ≥ 20 U.I., toxoidum pertussis 8 µg, haemagglutininum filamentosum von Bordetella pertussis 8 µg, pertactinum von Bordetella pertussis 2.5 µg, virus poliomyelitis typus 1 inactivatus 40 U., virus poliomyelitis typus 2 inactivatus 8 U., virus poliomyelitis typus 3 inactivatus 32 U., natrii chloridum corresp. natrium 1.8 mg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem et aluminii phosphas, medium 199, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, polysorbatum 80, formaldehydum.

Articles (1)

Boostrix Polio, Injektionssuspension
Injektionssuspension
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
26/06/2025
Professional SmPC
Français
26/06/2025
Professional SmPC
Italien
26/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
8.0 UG Substance Wirkstoff (Principe actif)
(N/A)
8.0 UG Substance Wirkstoff (Principe actif)
(N/A)
2.5 UG Substance Wirkstoff (Principe actif)
(N/A)
40.0 U Substance Wirkstoff (Principe actif)
(N/A)
8.0 U Substance Wirkstoff (Principe actif)
(N/A)
32.0 U Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
1.8 MG Substance HBESI
(N/A)
0.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance RESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI
(N/A)
- Substance RESI

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
681
Drug name
Boostrix Polio, Injektionssuspension
Galenic form
SUPA
ATC Code
J07CA02
Authorization status
Z
Dispensation category
B
First authorization
01/04/2004
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Auffrischimpfung gegen Diphtherie, Tetanus, Pertussis und Poliomyelitis, ab dem vollendeten 4. Lebensjahr

Packaging details

Description (FR)
BOOSTRIX Polio susp inj (n ser pré) 10 x 0.5 ml
Description (DE)
BOOSTRIX Polio Inj Susp (n Fertspr) 10 x 0.5 ml
Market launch
01/04/2004
Narcotic (BTM)
No

Application methods

IMU

Other packaging sizes

BOOSTRIX Polio susp inj ser pré 0.5 ml
None None
View
BOOSTRIX Polio susp inj (n ser pré) ser pré 0.5 ml
1 FESP
View